Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Official NIH NLM MEDLINE / PubMed Citation • PMID: 42980701 • DOI: 10.1007/s10103-026-05059-0

Effect of high-power radiofrequency combined with a hypocaloric diet on abdominal subcutaneous and visceral fat: a preliminary randomized pilot study.

Lasers in medical science • 2026 Nov • Vol. 41 (1) • ISSN 1435-604X
Authors: Sidra Kouser, Jesús Rodríguez Lastra, Carmen Torrejon Rueda
Inneo Clinic, Barcelona, Spain. sidra8384@gmail.com.

Verbatim Formal Study Abstract

ABSTRACT

Visceral and subcutaneous abdominal fat are associated with metabolic and cardiovascular risk. This preliminary randomized pilot study evaluated a high-power radiofrequency energy-based device (EBD) treatment, alone or combined with a hypocaloric dietary intervention, for visceral and subcutaneous abdominal fat reduction. Twenty middle-aged participants were randomly allocated to one of two parallel groups: EBD combined with dietary intervention (7 males, 3 females; mean age 58.2 ± 8.89 years) and EBD alone (5 males, 5 females; mean age 54.4 ± 12.5 years). Both groups received 12 EBD sessions over 6 weeks using a four-channel high-power radiofrequency device. Anthropometric, biochemical, and volumetric abdominal fat measurements were assessed at baseline and post-treatment, with visceral fat additionally evaluated at the 3-month follow-up. Both groups demonstrated reductions in abdominal fat volume. The EBD + diet group showed greater reductions in visceral fat (15.0%) and subcutaneous fat (18.6%) than the EBD-only group, which showed reductions of approximately 9.1% and 9.2%, respectively. Between-group change-score analyses favored the EBD + Diet group for weight and BMI, while differences in visceral and subcutaneous fat did not reach statistical significance. Most biochemical variables showed no clear between-group differences, although exploratory between-group differences were observed for triglycerides, insulin, and HOMA-IR. At the 3-month follow-up, mean visceral fat remained below baseline in both groups. Reductions in visceral and subcutaneous abdominal fat were observed in both treated groups. These findings should be interpreted cautiously due to the exploratory design and small sample size. Larger studies are required to confirm efficacy and long-term outcomes.

Publication Classification: Journal Article Randomized Controlled Trial
NLM MeSH Descriptors: Humans Female Middle Aged Pilot Projects Male Intra-Abdominal Fat Caloric Restriction Subcutaneous Fat, Abdominal Diet, Reducing Adult Aged Radiofrequency Therapy Body Mass Index Treatment Outcome